Oxycodone Hydrochloride
NDC Package 64950-353-52
Package Information
Oxycodone Hydrochloride is oral Solution is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.Limitations of UseBecause of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, [see Warnings and Precautions (5.2)], reserve Oxycodone Hydrochloride Oral Solution for use in patients for whom alternative treatment options [e.g., non-opioid analgesics or opioid combination products]:Have not been tolerated, or are not expected to be tolerated,Have not provided adequate analgesia, or are not expected to provide adequate analgesia. Marketed by Genus Lifesciences Inc., this product is identified by NDC 64950-353 and is authorized under FDA application NDA200535.
Identification & Billing
- RxCUI: 1049604 - oxyCODONE HCl 5 MG in 5 mL Oral Solution
- RxCUI: 1049604 - oxycodone hydrochloride 1 MG/ML Oral Solution
- RxCUI: 1049604 - oxycodone hydrochloride 5 MG per 5 ML Oral Solution
- RxCUI: 1049615 - oxyCODONE HCl 20 MG in 1 mL Concentrate for Oral Solution
- RxCUI: 1049615 - oxycodone hydrochloride 20 MG/ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 64950 - Genus Lifesciences Inc.
- 64950-353 - Oxycodone Hydrochloride
- 64950-353-52 - 50 POUCH in 1 CASE / 5 SYRINGE, PLASTIC in 1 POUCH (64950-353-92) / 1 mL in 1 SYRINGE, PLASTIC (64950-353-02)
- 64950-353 - Oxycodone Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (64950-353). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 64950-353-52 identifies a specific commercial package of 50 pouch in 1 case / 5 syringe, plastic in 1 pouch (64950-353-92) / 1 ml in 1 syringe, plastic (64950-353-02) of Oxycodone Hydrochloride, labeled by Genus Lifesciences Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Genus Lifesciences Inc. on October 20, 2010. The current certification is valid through December 01, 2021.
How is this Genus Lifesciences Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 64950035352. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.